nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—Metformin—metabolic syndrome X	0.751	1	CbGbCtD
Amphetamine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00972	0.281	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00653	0.189	CbGeAlD
Amphetamine—SLC18A2—adipose tissue—metabolic syndrome X	0.00186	0.0537	CbGeAlD
Amphetamine—CYP2A6—adipose tissue—metabolic syndrome X	0.00166	0.048	CbGeAlD
Amphetamine—SLC22A3—kidney—metabolic syndrome X	0.00147	0.0424	CbGeAlD
Amphetamine—MAOB—cardiovascular system—metabolic syndrome X	0.00139	0.0401	CbGeAlD
Amphetamine—MAOB—kidney—metabolic syndrome X	0.00136	0.0393	CbGeAlD
Amphetamine—SLC22A3—adipose tissue—metabolic syndrome X	0.00132	0.0382	CbGeAlD
Amphetamine—SLC18A2—liver—metabolic syndrome X	0.0013	0.0377	CbGeAlD
Amphetamine—MAOB—adipose tissue—metabolic syndrome X	0.00123	0.0354	CbGeAlD
Amphetamine—CYP2A6—liver—metabolic syndrome X	0.00116	0.0336	CbGeAlD
Amphetamine—SLC22A5—kidney—metabolic syndrome X	0.00107	0.0309	CbGeAlD
Amphetamine—SLC22A5—adipose tissue—metabolic syndrome X	0.000963	0.0278	CbGeAlD
Amphetamine—SLC22A3—liver—metabolic syndrome X	0.000929	0.0268	CbGeAlD
Amphetamine—MAOB—liver—metabolic syndrome X	0.00086	0.0248	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—metabolic syndrome X	0.000758	0.425	CrCbGaD
Amphetamine—Nateglinide—PPARG—metabolic syndrome X	0.000744	0.418	CrCbGaD
Amphetamine—CYP2D6—kidney—metabolic syndrome X	0.00069	0.0199	CbGeAlD
Amphetamine—SLC22A5—liver—metabolic syndrome X	0.000675	0.0195	CbGeAlD
Amphetamine—CYP2D6—liver—metabolic syndrome X	0.000436	0.0126	CbGeAlD
Amphetamine—Nateglinide—ALB—metabolic syndrome X	0.00028	0.157	CrCbGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000187	0.000883	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000181	0.000852	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00018	0.000849	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000179	0.000846	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000179	0.000842	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000176	0.000828	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TRIB3—metabolic syndrome X	0.000175	0.000825	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—G6PD—metabolic syndrome X	0.000174	0.000821	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000174	0.000819	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—metabolic syndrome X	0.000173	0.000818	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	0.000173	0.000815	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF2—metabolic syndrome X	0.000172	0.000813	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000171	0.000807	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.00017	0.000804	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HDAC3—metabolic syndrome X	0.00017	0.000801	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PPARG—metabolic syndrome X	0.000168	0.000792	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOB—metabolic syndrome X	0.000167	0.000789	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FMO3—metabolic syndrome X	0.000167	0.000785	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LPA—metabolic syndrome X	0.000166	0.000783	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GCKR—metabolic syndrome X	0.000166	0.000783	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000165	0.000778	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000165	0.000777	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL5—metabolic syndrome X	0.000163	0.00077	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000163	0.000767	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR1—metabolic syndrome X	0.000162	0.000765	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PLA2G6—metabolic syndrome X	0.000161	0.000758	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LPL—metabolic syndrome X	0.00016	0.000753	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOA5—metabolic syndrome X	0.000159	0.000751	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NAMPT—metabolic syndrome X	0.000157	0.00074	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LIPC—metabolic syndrome X	0.000156	0.000735	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GCK—metabolic syndrome X	0.000156	0.000735	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOC3—metabolic syndrome X	0.000155	0.000731	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—metabolic syndrome X	0.000154	0.000724	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	0.000153	0.000722	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000152	0.000716	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000151	0.000714	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.000151	0.000713	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000151	0.000712	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CETP—metabolic syndrome X	0.00015	0.000709	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MLXIPL—metabolic syndrome X	0.000148	0.0007	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—EPHX2—metabolic syndrome X	0.000148	0.0007	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TRIB3—metabolic syndrome X	0.000148	0.000698	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000144	0.000679	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SCARB1—metabolic syndrome X	0.000144	0.000679	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000142	0.000672	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000142	0.000669	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00014	0.00066	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SREBF1—metabolic syndrome X	0.00014	0.000659	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—G6PC2—metabolic syndrome X	0.00014	0.000658	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000138	0.000651	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AGT—metabolic syndrome X	0.000137	0.000644	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HMGCR—metabolic syndrome X	0.000136	0.000641	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT2—metabolic syndrome X	0.000136	0.000641	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOE—metabolic syndrome X	0.000134	0.000631	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LEP—metabolic syndrome X	0.000134	0.000631	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NAMPT—metabolic syndrome X	0.000133	0.000626	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOA1—metabolic syndrome X	0.000132	0.000624	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LIPC—metabolic syndrome X	0.000132	0.000622	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GCK—metabolic syndrome X	0.000132	0.000622	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOC3—metabolic syndrome X	0.000131	0.000618	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000131	0.000618	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000131	0.000615	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—metabolic syndrome X	0.000128	0.000605	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CETP—metabolic syndrome X	0.000127	0.0006	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000126	0.000593	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000124	0.000585	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SCARB1—metabolic syndrome X	0.000122	0.000575	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCA1—metabolic syndrome X	0.000121	0.000572	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SLC2A4—metabolic syndrome X	0.000121	0.000572	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IRS1—metabolic syndrome X	0.000119	0.000563	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000119	0.000561	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FABP4—metabolic syndrome X	0.000119	0.000559	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SREBF1—metabolic syndrome X	0.000118	0.000558	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000118	0.000557	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—metabolic syndrome X	0.000118	0.000555	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT1—metabolic syndrome X	0.000117	0.000554	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GGT1—metabolic syndrome X	0.000117	0.000554	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HMGCR—metabolic syndrome X	0.000115	0.000543	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT2—metabolic syndrome X	0.000115	0.000543	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—INS—metabolic syndrome X	0.000114	0.000539	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000114	0.000536	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000113	0.000532	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL2—metabolic syndrome X	0.000113	0.000531	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000112	0.00053	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HSD11B1—metabolic syndrome X	0.000112	0.00053	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000111	0.000523	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF1—metabolic syndrome X	0.000111	0.000522	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AGT—metabolic syndrome X	0.000105	0.000496	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000105	0.000495	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000105	0.000493	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCA1—metabolic syndrome X	0.000103	0.000484	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SLC2A4—metabolic syndrome X	0.000103	0.000484	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000102	0.000481	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOS3—metabolic syndrome X	0.0001	0.000473	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—G6PD—metabolic syndrome X	0.0001	0.000473	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOB—metabolic syndrome X	9.97e-05	0.00047	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GGT1—metabolic syndrome X	9.94e-05	0.000468	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT1—metabolic syndrome X	9.94e-05	0.000468	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	9.82e-05	0.000463	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HDAC3—metabolic syndrome X	9.78e-05	0.000461	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PLA2G4A—metabolic syndrome X	9.7e-05	0.000457	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GHRL—metabolic syndrome X	9.68e-05	0.000456	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPA—metabolic syndrome X	9.56e-05	0.000451	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCKR—metabolic syndrome X	9.56e-05	0.000451	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LPL—metabolic syndrome X	9.52e-05	0.000449	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FMO3—metabolic syndrome X	9.34e-05	0.00044	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2C—metabolic syndrome X	9.27e-05	0.000437	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLA2G6—metabolic syndrome X	9.26e-05	0.000437	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA5—metabolic syndrome X	9.17e-05	0.000432	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—metabolic syndrome X	9.17e-05	0.000432	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CD36—metabolic syndrome X	9.04e-05	0.000426	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GHRL—metabolic syndrome X	8.79e-05	0.000414	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.78e-05	0.000414	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL2—metabolic syndrome X	8.66e-05	0.000408	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.6e-05	0.000405	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TRIB3—metabolic syndrome X	8.52e-05	0.000402	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—metabolic syndrome X	8.46e-05	0.000399	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOB—metabolic syndrome X	8.43e-05	0.000398	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARA—metabolic syndrome X	8.41e-05	0.000396	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—metabolic syndrome X	8.32e-05	0.000392	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	8.32e-05	0.000392	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	8.32e-05	0.000392	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PLA2G4A—metabolic syndrome X	8.2e-05	0.000387	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AGT—metabolic syndrome X	8.14e-05	0.000384	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LPL—metabolic syndrome X	8.05e-05	0.00038	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOE—metabolic syndrome X	7.98e-05	0.000376	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOA1—metabolic syndrome X	7.89e-05	0.000372	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HDAC3—metabolic syndrome X	7.87e-05	0.000371	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	7.82e-05	0.000369	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AKT1—metabolic syndrome X	7.81e-05	0.000368	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.78e-05	0.000367	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CD36—metabolic syndrome X	7.65e-05	0.000361	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NAMPT—metabolic syndrome X	7.65e-05	0.00036	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LIPC—metabolic syndrome X	7.6e-05	0.000358	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCK—metabolic syndrome X	7.6e-05	0.000358	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOC3—metabolic syndrome X	7.55e-05	0.000356	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CETP—metabolic syndrome X	7.33e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—metabolic syndrome X	7.2e-05	0.000339	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARA—metabolic syndrome X	7.11e-05	0.000335	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—metabolic syndrome X	7.11e-05	0.000335	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTNR1B—metabolic syndrome X	7.03e-05	0.000331	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SCARB1—metabolic syndrome X	7.02e-05	0.000331	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—metabolic syndrome X	6.95e-05	0.000328	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AGT—metabolic syndrome X	6.89e-05	0.000325	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TRIB3—metabolic syndrome X	6.85e-05	0.000323	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RBP4—metabolic syndrome X	6.85e-05	0.000323	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—INS—metabolic syndrome X	6.82e-05	0.000321	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SREBF1—metabolic syndrome X	6.81e-05	0.000321	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—metabolic syndrome X	6.75e-05	0.000318	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOA1—metabolic syndrome X	6.67e-05	0.000315	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FABP4—metabolic syndrome X	6.65e-05	0.000314	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—metabolic syndrome X	6.64e-05	0.000313	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMGCR—metabolic syndrome X	6.63e-05	0.000312	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—metabolic syndrome X	6.63e-05	0.000312	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—metabolic syndrome X	6.45e-05	0.000304	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	6.43e-05	0.000303	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	6.31e-05	0.000297	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—metabolic syndrome X	6.25e-05	0.000295	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOC3—metabolic syndrome X	6.07e-05	0.000286	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—metabolic syndrome X	5.98e-05	0.000282	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGT—metabolic syndrome X	5.94e-05	0.00028	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC2A4—metabolic syndrome X	5.91e-05	0.000279	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCA1—metabolic syndrome X	5.91e-05	0.000279	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—metabolic syndrome X	5.88e-05	0.000277	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INS—metabolic syndrome X	5.77e-05	0.000272	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—metabolic syndrome X	5.72e-05	0.00027	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—metabolic syndrome X	5.72e-05	0.00027	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—G6PD—metabolic syndrome X	5.62e-05	0.000265	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	5.49e-05	0.000259	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2C—metabolic syndrome X	5.48e-05	0.000258	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—metabolic syndrome X	5.47e-05	0.000258	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—metabolic syndrome X	5.4e-05	0.000254	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCKR—metabolic syndrome X	5.36e-05	0.000253	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPA—metabolic syndrome X	5.36e-05	0.000253	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBA—metabolic syndrome X	5.31e-05	0.00025	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—metabolic syndrome X	5.29e-05	0.000249	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	5.19e-05	0.000245	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GHRL—metabolic syndrome X	5.19e-05	0.000245	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA5—metabolic syndrome X	5.14e-05	0.000242	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—metabolic syndrome X	5.06e-05	0.000238	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—metabolic syndrome X	5e-05	0.000236	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—metabolic syndrome X	4.92e-05	0.000232	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOB—metabolic syndrome X	4.86e-05	0.000229	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	4.78e-05	0.000225	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLA2G4A—metabolic syndrome X	4.72e-05	0.000223	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—metabolic syndrome X	4.64e-05	0.000219	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—metabolic syndrome X	4.62e-05	0.000218	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—metabolic syndrome X	4.61e-05	0.000217	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—metabolic syndrome X	4.45e-05	0.00021	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD36—metabolic syndrome X	4.41e-05	0.000208	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	4.29e-05	0.000202	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LIPC—metabolic syndrome X	4.26e-05	0.000201	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCK—metabolic syndrome X	4.26e-05	0.000201	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOC3—metabolic syndrome X	4.23e-05	0.0002	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CETP—metabolic syndrome X	4.11e-05	0.000194	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARA—metabolic syndrome X	4.1e-05	0.000193	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	4.02e-05	0.00019	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—metabolic syndrome X	3.97e-05	0.000187	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	3.94e-05	0.000186	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOB—metabolic syndrome X	3.9e-05	0.000184	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—metabolic syndrome X	3.89e-05	0.000183	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA1—metabolic syndrome X	3.84e-05	0.000181	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	3.82e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	3.81e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.8e-05	0.000179	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—metabolic syndrome X	3.73e-05	0.000176	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—metabolic syndrome X	3.72e-05	0.000175	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	3.72e-05	0.000175	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—metabolic syndrome X	3.38e-05	0.00016	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INS—metabolic syndrome X	3.32e-05	0.000157	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	3.31e-05	0.000156	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	3.31e-05	0.000156	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—metabolic syndrome X	3.21e-05	0.000151	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—metabolic syndrome X	3.21e-05	0.000151	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—metabolic syndrome X	3.19e-05	0.00015	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—metabolic syndrome X	3.12e-05	0.000147	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—metabolic syndrome X	3.12e-05	0.000147	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	3.09e-05	0.000146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—metabolic syndrome X	3.04e-05	0.000143	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—metabolic syndrome X	2.91e-05	0.000137	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	2.79e-05	0.000131	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—metabolic syndrome X	2.75e-05	0.00013	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOB—metabolic syndrome X	2.72e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—INS—metabolic syndrome X	2.67e-05	0.000126	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—metabolic syndrome X	2.66e-05	0.000126	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	2.65e-05	0.000125	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	2.63e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—metabolic syndrome X	2.6e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	2.58e-05	0.000122	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD36—metabolic syndrome X	2.47e-05	0.000116	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	2.45e-05	0.000116	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	2.34e-05	0.00011	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—metabolic syndrome X	2.32e-05	0.00011	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	2.3e-05	0.000108	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—metabolic syndrome X	2.22e-05	0.000105	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—metabolic syndrome X	2.18e-05	0.000103	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	2.15e-05	0.000102	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	2.01e-05	9.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	1.97e-05	9.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.9e-05	8.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INS—metabolic syndrome X	1.86e-05	8.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	1.82e-05	8.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—metabolic syndrome X	1.71e-05	8.05e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	1.63e-05	7.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	1.55e-05	7.3e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	1.49e-05	7.04e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—metabolic syndrome X	1.34e-05	6.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	1.17e-05	5.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	1.08e-05	5.07e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	7.51e-06	3.54e-05	CbGpPWpGaD
